Our Story

Genecast was established in Beijing in 2014 and is headquartered in the city of Wuxi, Jiangsu Province. It boasts a total of more than 7000㎡ in operating space, with facilities in cities such as Beijing and Taizhou. This includes its CAP-certified precision medicine diagnostic laboratory, which holds a Practice License of Medical Institution, awarded by Wuxi City Health Commission; its precision tumor diagnosis and treatment big data center; and its GMP-compliant IVD reagents manufacturing base. 

Leadership
01——07
Bo Du
Founder & CEO
Henghui Zhang
Founder & Chief Medical Officer
Guosheng Ma
Founder & Executive Vice President
Tao Yang
Vice President & General Manager of Wuxi Site
Ji He
Chief Information Officer
Weizhi Chen
Chief Scientific Officer
Jerry Wang
Vice President, Corporate Development
Qualification
Inspection institute qualification
Corporate certificate
<
High-tech Enterprise.
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
Jiangsu Certification for EQA
<
Jiangsu Certification for EQA
<
Jiangsu Certification for EQA
<
CERTIFICATE
<
NCCL EQA Certificate
<
JIANGSU CERTIFICATION FOR EQA
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
CAP Accredited
<
High-tech Enterprise.
<
Zhongguancun High-tech Enterprise.
<
NGS Qualification
<
ARMS Qualification
<
High-tech Enterprise.
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
SCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
<
NCCL EQA Certificate
History

01-2016

Launch of Genecast Comprehensive

01-2016

“A Round” financing of 26 million RMB

01-2017

“B Round” financing of 128 million RMB

01-2018

"C Round" financing of 210 million RMB

01-2019

Awarded “Top 100 Growth Model of the Year” for Zhongguancun Area

02-2015

“Angel Round” financing of 2.5 million RMB

04-2017

Genecast (Wuxi) Precision Medicine Laboratory approved

04-2019

Launch of Immunoscore

06-2017

Launch of Genecast PD-L1

07-2017

Launch of Genecast Lung and Genecast CRC

07-2019

Launch of Medical Insurance

08-2019

Achieved strategic partnership agreement with AstraZeneca

09-2018

Achieved strategic partnership agreement with Illumina

09-2018

Launch of MammaPrint and BluePrint

09-2019

Obtained NGS Qualification

09-2019

Awarded “EY Fudan China the Most Promising Enterprises Award 2019”

09-2019

Achieved strategic partnership agreement with Interpace

10-2018

Launch of Tissue of Origin

10-2018

Accredited by College of American Pathologists(CAP)

10-2019

"D1 Round" financing of more than 300 million RMB

11-2014

Founded

11-2019

Launch of Genecast Lung Tils

12-2017

Awarded "TOP100 Growth Model Innovation of the Year"

12-2017

Awarded title of "National High-Tech Enterprise"

01-2016

Launch of Genecast Comprehensive

01-2016

“A Round” financing of 26 million RMB

01-2017

“B Round” financing of 128 million RMB

01-2018

"C Round" financing of 210 million RMB

01-2019

Awarded “Top 100 Growth Model of the Year” for Zhongguancun Area

02-2015

“Angel Round” financing of 2.5 million RMB

04-2017

Genecast (Wuxi) Precision Medicine Laboratory approved

04-2019

Launch of Immunoscore

06-2017

Launch of Genecast PD-L1

07-2017

Launch of Genecast Lung and Genecast CRC

07-2019

Launch of Medical Insurance

08-2019

Achieved strategic partnership agreement with AstraZeneca

09-2018

Achieved strategic partnership agreement with Illumina

09-2018

Launch of MammaPrint and BluePrint

09-2019

Obtained NGS Qualification

09-2019

Awarded “EY Fudan China the Most Promising Enterprises Award 2019”

09-2019

Achieved strategic partnership agreement with Interpace

10-2018

Launch of Tissue of Origin

10-2018

Accredited by College of American Pathologists(CAP)

10-2019

"D1 Round" financing of more than 300 million RMB

11-2014

Founded

11-2019

Launch of Genecast Lung Tils

12-2017

Awarded "TOP100 Growth Model Innovation of the Year"

12-2017

Awarded title of "National High-Tech Enterprise"

Press Releases
Careers

Genecast was established in Beijing in 2014 and is headquartered in the city of Wuxi, Jiangsu Province. With the second-generation sequencing technology and bioinformatics as the core, the company is engaged in non-invasive and precise diagnosis and diagnosis of tumors, and is committed to becoming a leader in improving the quality of life of cancer patients.With the second-generation sequencing technology and bioinformatics as the core, the company is engaged in non-invasive and precise diagnosis and diagnosis of tumors, and is committed to becoming a leader in improving the quality of life of cancer patients.

Email :zhaopin@genecast.com.cn
Job Responsibilities
  • · Quality Manager
  • · Product Manager
  • · Sales Representative
  • · Sales Assistant
  • · Medical Specialist
  • · Customer Service
Contact Us

We are committed to being improved
the leader in the quality of life of cancer patients.